Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia

• Published in: The American journal of emergency medicine 2012-03, Vol.30 (3), p.456-463
• Main Authors: Trottier, Evelyne D., MD, Bailey, Benoit, MD, Lucas, Nathalie, MD, Lortie, Anne, MD
• Format: Article
• Language: English
• Subjects: Adolescent; Akathisia, Drug-Induced - epidemiology; Akathisia, Drug-Induced - etiology; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Biological and medical sciences; Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis; Child; Diphenhydramine - therapeutic use; Dopamine Antagonists - adverse effects; Dopamine Antagonists - therapeutic use; Drug Therapy, Combination; Emergency; Emergency medical care; Emergency Service, Hospital; Female; Follow-Up Studies; Headaches; Hospitalization; Humans; Hypnotics and Sedatives - therapeutic use; Intensive care medicine; Male; Medical sciences; Medical treatment; Migraine Disorders - complications; Migraine Disorders - drug therapy; Pain; Pediatrics; Placebo effect; Prochlorperazine - adverse effects; Prochlorperazine - therapeutic use; Prospective Studies; Questionnaires; Recurrence; Transfusions. Complications. Transfusion reactions. Cell and gene therapy; Treatment Outcome
• ISSN: 0735-6757; 1532-8171
• DOI: 10.1016/j.ajem.2010.12.020

Abstract Objective The objective of this study is to evaluate the effectiveness of prochlorperazine and the rate of akathisia in children with severe migraine. Methods The study is a prospective cohort of a convenient sample of patients younger than 18 years old diagnosed with migraine and treated with intravenous prochlorperazine in adjunction with diphenhydramine in the emergency department. The evaluation of pain and akathisia was performed before the treatment and was repeated 60 minutes later and before discharge. A telephone follow-up was completed to assess relapse in pain and presence of akathisia. The effectiveness of prochlorperazine was determined using different outcomes: 50% reduction of pain, pain-free patients, treatment failure, and relapse of pain. Results Of the 79 patients included in the study for 25 months, 64 (81%) either met the International Headache Society criteria or had a diagnosis of migraine confirmed by a neurologist at follow-up. Among these patients, 47 (100%) of 47 had a 50% reduction of pain, and 24 (50%) of 48 were pain free at discharge. Only 14 (22%) of 64 patients had a treatment failure. However, 43 (68%) of 63 patients had a relapse of their headache within the first week after discharge. Overall, among the 79 patients, 4 (5%) had a definitive diagnosis of akathisia, but 27 (34%) other patients presented symptoms suggesting a possible diagnosis of akathisia. Conclusion Prochlorperazine seems very effective to decrease pain on a short-term basis in children. However, more than two thirds of the patients, overall, had a relapse of their migraine at home in the first week. Despite the use of diphenhydramine, akathisia remains a concern.